Bortezomib 70511-0161-05
- Manufacturer
- Maia Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 11, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA215331
Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bortezomib | 1 mg/1 |
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]
Selected Package
70511-0161-05Selected1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-161-05)